Intracellularly, CLU has been found to bind and inactivate apoptosis regulator BAX (BAX), thereby altering the ratio between pro-apoptotic BAX and anti-apoptotic B-Cell CLL/Lymphoma 2 proteins towards a pro-survival level [72, 73]. The gene discussed is CLU; the disease is B-cell chronic lymphocytic leukemia.